Rino Rappuoli

InstitutionGSK Vaccines
AddressSiena
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 12 Covid-19 publications, with a maximum of 3 publications in October 2020
    All Publications
    Bar chart showing 549 publications over 27 distinct years, with a maximum of 31 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Andreano E, Piccini G, Licastro D, Casalino L, Johnson NV, Paciello I, Dal Monego S, Pantano E, Manganaro N, Manenti A, Manna R, Casa E, Hyseni I, Benincasa L, Montomoli E, Amaro RE, McLellan JS, Rappuoli R. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. Proc Natl Acad Sci U S A. 2021 09 07; 118(36). PMID: 34417349.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    2. Andreano E, Rappuoli R. Immunodominant antibody germlines in COVID-19. J Exp Med. 2021 05 03; 218(5). PMID: 33656515.
      Citations: 6     Fields:    Translation:HumansCells
    3. Andreano E, Rappuoli R. SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies. Nat Med. 2021 05; 27(5):759-761. PMID: 33972793.
      Citations: 9     Fields:    Translation:Humans
    4. Citations: 29     Fields:    Translation:AnimalsCells
    5. Citations: 38     Fields:    Translation:HumansAnimalsCells
    6. Pecetta S, Pizza M, Sala C, Andreano E, Pileri P, Troisi M, Pantano E, Manganaro N, Rappuoli R. Antibodies, epicenter of SARS-CoV-2 immunology. Cell Death Differ. 2021 02; 28(2):821-824. PMID: 33500559.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    7. Rappuoli R, De Gregorio E, Del Giudice G, Phogat S, Pecetta S, Pizza M, Hanon E. Vaccinology in the post-COVID-19 era. Proc Natl Acad Sci U S A. 2021 01 19; 118(3). PMID: 33431690.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    8. Almond J, Hacker J, Harwood C, Pizza M, Rappuoli R, Ron EZ, Sansonetti P, Vanderslott S, Wieler LH. Development of vaccines at the time of COVID-19. Microlife. 2020 Jul; 1(1):uqaa003. PMID: 34235437.
      Citations:    
    9. Ciabattini A, Garagnani P, Santoro F, Rappuoli R, Franceschi C, Medaglini D. Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population. Semin Immunopathol. 2020 10; 42(5):619-634. PMID: 33159214.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    10. Black S, Bloom DE, Kaslow DC, Pecetta S, Rappuoli R. Transforming vaccine development. Semin Immunol. 2020 08; 50:101413. PMID: 33127296.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    11. Troisi M, Andreano E, Sala C, Kabanova A, Rappuoli R. Vaccines as remedy for antimicrobial resistance and emerging infections. Curr Opin Immunol. 2020 08; 65:102-106. PMID: 33289646.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    12. Rappuoli R. Timeline: Vaccines. Cell. 2020 10 15; 183(2):552. PMID: 33064991.
      Citations: 1     Fields:    
    13. Kong WP, Xu L, Stadler K, Ulmer JB, Abrignani S, Rappuoli R, Nabel GJ. Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization. J Virol. 2005 Nov; 79(22):13915-23. PMID: 16254327.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    14. Stadler K, Rappuoli R. SARS: understanding the virus and development of rational therapy. Curr Mol Med. 2005 Nov; 5(7):677-97. PMID: 16305493.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    15. Stadler K, Roberts A, Becker S, Vogel L, Eickmann M, Kolesnikova L, Klenk HD, Murphy B, Rappuoli R, Abrignani S, Subbarao K. SARS vaccine protective in mice. Emerg Infect Dis. 2005 Aug; 11(8):1312-4. PMID: 16110580.
      Citations: 21     Fields:    Translation:AnimalsCellsPHPublic Health
    16. Song HC, Seo MY, Stadler K, Yoo BJ, Choo QL, Coates SR, Uematsu Y, Harada T, Greer CE, Polo JM, Pileri P, Eickmann M, Rappuoli R, Abrignani S, Houghton M, Han JH. Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein. J Virol. 2004 Oct; 78(19):10328-35. PMID: 15367599.
      Citations: 53     Fields:    Translation:AnimalsCells
    17. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med. 2004 Aug; 10(8):871-5. PMID: 15247913.
      Citations: 310     Fields:    Translation:HumansAnimalsCells
    18. Stadler K, Masignani V, Eickmann M, Becker S, Abrignani S, Klenk HD, Rappuoli R. SARS--beginning to understand a new virus. Nat Rev Microbiol. 2003 Dec; 1(3):209-18. PMID: 15035025.
      Citations: 194     Fields:    Translation:HumansAnimalsCells
    19. Eickmann M, Becker S, Klenk HD, Doerr HW, Stadler K, Censini S, Guidotti S, Masignani V, Scarselli M, Mora M, Donati C, Han JH, Song HC, Abrignani S, Covacci A, Rappuoli R. Phylogeny of the SARS coronavirus. Science. 2003 Nov 28; 302(5650):1504-5. PMID: 14645828.
      Citations: 46     Fields:    Translation:Cells
    Rappuoli's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (339)
    Explore
    _
    Co-Authors (137)
    Explore
    _
    Similar People (60)
    Explore
    _